Clinical trial
A Double-Blind, Randomized, Three-Arm, Parallel-Group Study to Assess the Efficacy and Safety of Two Doses of Pridopidine Versus Placebo for the Treatment of Levodopa-Induced Dyskinesia in Patients With Parkinson's Disease (gLIDe)
NCT03922711 is registered in ClinicalTrials.gov with Prilenia as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Double-Blind, Randomized, Three-Arm, Parallel-Group Study to Assess the Efficacy and Safety of Two Doses of Pridopidine Versus Placebo for the Treatment of Levodopa-Induced Dyskinesia in Patients With Parkinson's Disease (gLIDe)
- Lead sponsor
- Prilenia
- Phase
- Phase 2
- Overall status
- Terminated
- Start date
- May 22, 2019
- Completion date
- July 22, 2020
- Enrollment
- 23 (actual)
- Sites
- 33
Conditions
As the registry lists them; a condition with its own page is linked.